SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents-Reference-Cited by-同舟云学术

SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents

Published:2022-06-01 Issue:6 Volume:7 Page:600
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Karlstad Øystein¹,Hovi Petteri²,Husby Anders³⁴,Härkänen Tommi²,Selmer Randi Marie¹,Pihlström Nicklas⁵,Hansen Jørgen Vinsløv³,Nohynek Hanna⁶,Gunnes Nina¹⁷,Sundström Anders⁸,Wohlfahrt Jan³,Nieminen Tuomo A.⁹,Grünewald Maria⁵,Gulseth Hanne Løvdal¹,Hviid Anders³¹⁰,Ljung Rickard⁸¹¹

Affiliation:

1. Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway

2. Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland

3. Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark

4. Department of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom

5. Division of Licensing, Swedish Medical Products Agency, Uppsala, Sweden

6. Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland

7. Norwegian Research Centre for Women’s Health, Oslo University Hospital, Oslo, Norway

8. Division of Use and Information, Swedish Medical Products Agency, Uppsala, Sweden

9. Information Services, Finnish Institute for Health and Welfare, Helsinki, Finland

10. Department of Drug Design and Pharmacology, Pharmacovigilance Research Center, University of Copenhagen, Copenhagen, Denmark

11. Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Link

https://jamanetwork.com/journals/jamacardiology/articlepdf/2791253/jamacardiology_karlstad_2022_oi_220012_1654532426.73967.pdf

Reference41 articles.

1. Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel

2. Myocarditis after Covid-19 Vaccination in a Large Health Care Organization

3. Surveillance for adverse events after COVID-19 mRNA vaccination.;Klein;JAMA,2021

4. Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military.;Montgomery;JAMA Cardiol,2021

5. The profile of the Covid-19 vaccination register safety study in Sweden (CoVacSafe-SE).;Ljung;Ups J Med Sci,2021

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myocarditis and pericarditis risk with mRNA COVID-19 vaccination compared to unvaccinated individuals: A retrospective cohort study in a Spanish Tertiary Hospital;Biomedicine & Pharmacotherapy;2024-02

2. COVID-19 Vaccine Effectiveness Among Adolescents;Pediatrics;2024-01-10

3. Long term follow up and outcomes of Covid-19 vaccine associated myocarditis in Victoria, Australia: A clinical surveillance study;Vaccine;2024-01

4. Adverse Events Following SARS-CoV-2 mRNA Vaccination in Adolescents: A Norwegian Nationwide Register-Based Study;2023-12-21

5. COVID-19 vaccine-associated myocarditis: Analysis of the suspected cases reported to the EudraVigilance and a systematic review of the published literature;IJC Heart & Vasculature;2023-12